Clinical studies are the key source of knowledge in the field of global health. However, for a variety of reasons, some studies end without informative results, meaning that the time and effort that went into them did not improve or save lives.
Design, Analyze, Communicate (DAC) started as a Bill & Melinda Gates Foundation program to help grantees optimize studies for informativeness and impact. DAC includes an evidence-based catalogue of best practices, assessments, open-source simulation software, and other tools for researchers. Since these approaches and tools can benefit not only Gates Foundation grantees but the broader global health clinical research community, the Global Health Network helped the Gates Foundation launch a publicly available version, the DAC Trials Knowledge Hub.
DAC principles, such as Best Practices for Study Informativeness, are translatable across clinical trials and studies as well as implementation research.
To explore the Hub, click on the buttons or links below to enter each area or focused area, respectively, or navigate using the drop-down menus in the bar above.
Please note: Implementors of studies should also always refer to relevant regulatory standards and guidelines (e.g. FDA, EMA) to assist with study/protocol design.